Germany: Aventis to develop with Coley

Article Abstract:

Aventis Pharma and US Coley Pharmaceutical Group Inc will join forces in the field of product development and licensing. Through this deal, Aventis gets the worldwide exclusive rights for the development of asthma and allergic rhinitis drugs which use the new immunmodulators (CpG) developed by Coley.

United States, Foreign operations, Joint ventures, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Strategic alliances, Respiratory Preparations, Respiratory system agents, Aventis S.A., Aventis Pharma AG, AVE

---

GERMANY: NEW TEST FOR THROMBOSIS THERAPY MONITORING

Article Abstract:

By the end of 2001 a German Jena-based company called Haemosys GmbH is to launch PADA test, which allows the monitoring of thrombosis therapy. The test that controls the adhesion of platelets is said to be the first such product in the market.

Product information, Medical Instruments and Supplies, Medical Equipment and Supplies Manufacturing, Cardiovascular Diagnostic Equip, Diagnostic equipment (Medical), Cardiovascular equipment, Haemosys GmbH

---

Similar abstracts:

• Abstracts: GERMANY: SCHERING IN CONTRAST AGENT DEAL. GERMANY/SWITZERLAND: WAGNER AUTOMOBIL TO EMS. GERMANY/US: GRAPHICAL FILMS BY NESCHEN, GBC

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.